These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6142747)

  • 1. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Fagard R; Knockaert D
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenalterol in the treatment of orthostatic hypotension in Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Knockaert D; Fagard R; Fiocchi R; Amery A; Lijnen P
    Acta Cardiol; 1984; 39(2):147-55. PubMed ID: 6145274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).
    West JN; Stallard TJ; Dimmitt SB; Smith SA; Williams A; Littler WA
    Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological aspects of the Shy-Drager syndrome: a urodynamic and telemetric investigation. Incontinence treatment by electrical pacemaker and prenalterol.
    Vereecken RL; Goovaerts J; Knockaert D; Joossens J; Sansen W
    Eur Urol; 1985; 11(1):65-8. PubMed ID: 2859197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin and propranolol combined treatment for Shy-Drager syndrome.
    Galassi G
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylsalicylic acid and indomethacin in the treatment of idiopathic orthostatic hypotension and Shy-Drager's syndrome].
    Hinge HH; Mikkelsen B; Korsager S
    Ugeskr Laeger; 1985 Apr; 147(14):1196-8. PubMed ID: 4002380
    [No Abstract]   [Full Text] [Related]  

  • 10. [Idiopathic orthostatic hypotension (Shy-Drager syndrome). Clinical and hemodynamic studies of a case].
    Russo R; Permutti B; Crociani P; Bortolotti U; Fernandez P; Schivazappa L
    Minerva Med; 1981 Oct; 72(39):2621-4. PubMed ID: 7290466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
    Rae-Grant A; Young GB; Spence JD
    Neurology; 1985 Jul; 35(7):1085-6. PubMed ID: 4010957
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome.
    Brevetti G; Chiariello M; Giudice P; De Michele G; Mansi D; Campanella G
    Am Heart J; 1981 Nov; 102(5):938-41. PubMed ID: 7304404
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
    Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of prenalterol on dialysis-associated hypotension.
    Ladefoged J
    Eur J Clin Pharmacol; 1984; 26(3):399-400. PubMed ID: 6145594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope.
    Lamarre-Cliche M
    Am J Cardiovasc Drugs; 2002; 2(1):23-35. PubMed ID: 14727996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial hypotension.syncope in Shy-Drager syndrome and its treatment with oral L-DOPS].
    Hasegawa Y; Koike Y; Matsuoka Y; Takahashi A
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):939-43. PubMed ID: 2507719
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the treatment of orthostatic hypotension.
    Robertson D; Davis TL
    Neurology; 1995 Apr; 45(4 Suppl 5):S26-32. PubMed ID: 7746370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic orthostatic hypotension and the Shy-Drager syndrome: hemodynamic and pharmacological studies in seven patients (author's transl)].
    de Rohan-Chabot P; Said G; Ziza JM
    Ann Med Interne (Paris); 1980; 131(8):483-8. PubMed ID: 7013598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shy-Drager syndrome: a rare cause of orthostatic hypotension].
    Oldenburg O; Karliova M; Koeppen S; Weber F; Erbel R; Philipp T; Kribben A
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):8-12. PubMed ID: 9951452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of Shy-Drager syndrome].
    Gubskiĭ LV
    Sov Med; 1989; (6):115-7. PubMed ID: 2799483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.